Skip to main content

Table 6 Association between CXCL9-11 haplotypes and liver fibrosis stage in HCV-infected patients

From: CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional study

  CXCL9-11 Haplotypes Association p
rs10336 rs3921 rs4619915 Freq. aOR (95% CI)
F ≥ 2 (≥7.1 kPa) G G G 0.581 0.95 (0.70; 1.30) 0.760
  A C A 0.401 1.01 (0.74;1.39) 0.929
  A G G 0.011 2.50 (0.59;10.5) 0.198
F ≥ 3 (≥9.5 kPa) G G G 0.581 0.97 (0.70;1.36) 0.868
  A C A 0.401 1.10 (0.78;1.54) 0.597
  A G G 0.011 0.32 (0.04;2.64) 0.226
F4 (≥12.5 kPa) G G G 0.581 0.91 (0.62;1.34) 0.629
  A C A 0.401 1.12 (0.76;1.66) 0.557
  A G G 0.011 0.58 (0.07;4.85) 0.591
  1. Statistical: p values were calculated by multivariate logistic regression adjusted by the most important clinical and epidemiological characteristics
  2. 95% CI 95% of confidence interval, aOR adjusted odds ratio, p value level of significance, F  2 significant fibrosis, F  3 advance fibrosis, F4 cirrhosis, HCV-GT hepatitis C virus genotype, CXCL chemokine (C-X-C motif) ligand